Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-22 to 2023-09-08
Current total value of award: $12485
Description: 4561899551!ATEZOLIZMAB 60MG/ML 1S